查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1266692

幹細胞化驗的全球市場:趨勢，機會，競爭分析(2023年～2028年)

Stem Cell Assay Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球幹細胞化驗的市場規模，預計從2023年至2028年以19.1％的年複合成長率成長，到2028年達到估計40億美元。促進市場成長的主要原因，是幹細胞的治療能力的認識高漲，目前幹細胞培養技術的接受率上升，癌症和心血管疾病的病例增加等。

本報告提供全球幹細胞化驗市場調查，市場概要，市場規模和預測，趨勢，促進因素、課題，各化驗類型、各細胞類型、各產品、各服務、各用途、各最終用途產業、各地區等的分析，再加上競爭分析等資訊。

目錄

第1章 摘要整理

第2章 全球幹細胞化驗市場:市場動態

  • 簡介，背景，及分類
  • 供應鏈
  • 產業的推動因素與課題

第3章 市場趨勢與預測分析(2017年～2028年)

  • 宏觀經濟趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球幹細胞化驗市場趨勢(2017年～2022年)與預測(2023年～2028年)
  • 全球幹細胞化驗市場:各化驗類型
    • 生存能力/細胞毒性
    • 分離、精製
    • 細胞鑑定
    • 增生
    • 分化
    • 功能
    • 細胞凋亡
    • 其他
  • 全球幹細胞化驗市場:各細胞類型
    • 成體幹細胞
    • 間質幹細胞
    • 誘導性多功能幹細胞
    • 造血幹細胞
    • 臍帶幹細胞
    • 神經幹細胞
    • 人類胚胎幹細胞
  • 全球幹細胞化驗市場:各產品、服務
    • 設備
    • 流式細胞儀
    • 微電極陣列
    • 細胞成像、分析系統
    • 自動細胞計數器
    • 套件
    • 服務
  • 全球幹細胞化驗市場:各用途
    • 再生醫療、治療開發
    • 整形外科，肌肉骨骼，脊椎
    • 皮膚科
    • 心血管
    • 中樞神經系統
    • 腫瘤學
    • 糖尿病
    • 藥物研發、開發
  • 全球幹細胞化驗市場:各最終用途產業
    • 生物醫藥品、生物科技企業
    • 學術、研究機關

第4章 市場趨勢與預測分析:各地區(2017年～2028年)

  • 各地區的幹細胞化驗市場
  • 北美的幹細胞化驗市場
    • 北美的幹細胞化驗市場，各化驗類型:生存能力/細胞毒性，分離、精製，細胞鑑定，增生，分化，功能，細胞凋亡，其他
    • 北美的幹細胞化驗市場，各最終用途產業:生物醫藥品、生物科技企業，學術、研究機關
  • 歐洲的幹細胞化驗市場
    • 歐洲的幹細胞化驗市場，各化驗類型:生存能力/細胞毒性，分離、精製，細胞鑑定，增生，分化，功能，細胞凋亡，其他
    • 歐洲的幹細胞化驗市場，各最終用途產業:生物醫藥品、生物科技企業，學術、研究機關
  • 亞太地區的幹細胞化驗市場
    • 亞太地區的幹細胞化驗市場，各化驗類型:生存能力/細胞毒性，分離、精製，細胞鑑定，增生，分化，功能，細胞凋亡，其他
    • 亞太地區的幹細胞化驗市場，各最終用途產業:生物醫藥品、生物科技企業，學術、研究機關
  • 其他地區的幹細胞化驗市場
    • 其他地區的幹細胞化驗市場，各化驗類型:生存能力/細胞毒性，分離、精製，細胞鑑定，增生，分化，功能，細胞凋亡，其他
    • 其他地區的幹細胞化驗市場，各最終用途產業:生物醫藥品、生物科技企業，學術、研究機關

第5章 競爭分析

  • 產品系列分析
  • 運用整合
  • 波特的五力分析

第6章 成長機會及策略分析

  • 成長機會分析
    • 全球幹細胞化驗市場成長機會:各化驗類型
    • 全球幹細胞化驗市場成長機會:各細胞類型
    • 全球幹細胞化驗市場成長機會:各產品、服務
    • 全球幹細胞化驗市場成長機會:各用途
    • 全球幹細胞化驗市場成長機會:各最終用途產業
    • 全球幹細胞化驗市場成長機會:各地區
  • 全球幹細胞化驗市場上新的趨勢
  • 策略分析
    • 新產品的開發
    • 全球幹細胞化驗市場通訊容量擴大
    • 全球幹細胞化驗市場的合併，收購，合資企業
    • 檢定和授權

第7章 主要企業的企業簡介

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories
簡介目錄

Stem Cell Assay Market Trends and Forecast

The future of the global stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes. The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028 with a CAGR of 19.1% from 2023 to 2028. The major drivers for this market are increasing awareness of the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.

A more than 150-page report is developed to help in your business decisions. A sample figure with some insights is shown below.

Stem Cell Assay Market by Segment

The study includes trends and forecast for the global stem cell assay market by type, cell type, product & service, application, end use industry, and region, as follows:

Stem Cell Assay Market by Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Viability or Cytotoxicity
  • Isolation and Purification
  • Cell Identification
  • Proliferation
  • Differentiation
  • Function
  • Apoptosis
  • Others

Stem Cell Assay Market by Cell Type [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Adult
  • Mesenchymal
  • Induced Pluripotent
  • Hematopoietic
  • Umbilical Cord
  • Neural
  • Human Embryonic

Stem Cell Assay Market by Product & Service [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Instruments
  • Flow Cytometers
  • Microelectrode Arrays
  • Cell Imaging & Analysis Systems
  • Automated Cell Counters
  • Kits
  • Services

Stem Cell Assay Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Regenerative Medicine & Therapy Development
  • Orthopedic, Musculoskeletal, and Spine Application
  • Dermatology Application
  • Cardiovascular Application
  • CNS Application
  • Oncology Application
  • Diabetes Application
  • Drug Discovery & Development
  • Clinical Research

Stem Cell Assay Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

  • Biopharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

Stem Cell Assay Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Stem Cell Assay Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, stem cell assay companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stem cell assay companies profiled in this report include-

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories

Stem Cell Assay Market Insights

  • Lucintel forecasts that viability/cytotoxicity assay will remain the largest type segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.
  • Within this market, the biopharmaceutical & biotechnology companies segment is expected to record the highest growth due to growing prevalence of chronic diseases, an increase in the number of clinical trials, and growing strategic activities along with improvements in healthcare services.
  • North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.

Features of the Stem Cell Assay Market

  • Market Size Estimates: Stem cell assay market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Stem cell assay market size by various segments, such as by type, cell type, product & service, application, end use industry, and region
  • Regional Analysis: Stem cell assay market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by type, cell type, product & service, application, end use industry, and regions for the stem cell assay market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the stem cell assay market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the stem cell assay market size?

Answer: The global stem cell assay market is expected to reach an estimated $4.0 billion by 2028.

Q2. What is the growth forecast for stem cell assay market?

Answer: The global stem cell assay market is expected to grow with a CAGR of 19.1% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the stem cell assay market?

Answer: The major drivers for this market are increasing awareness about the therapeutic potency of stem cells, rising acceptance of the current stem cell culture technology, and growing cases of cancer and cardiovascular diseases.

Q4. What are the major segments for stem cell assay market?

Answer: The future of the stem cell assay market looks promising with opportunities in biopharmaceutical & biotechnology companies and academic & research institutes.

Q5. Who are the key stem cell assay companies?

Answer: Some of the key stem cell assay companies are as follows:

  • Thermo Fisher Scientific
  • Merck KGaA
  • Danaher
  • Becton, Dickinson and Company
  • Agilent Technologies
  • Bio-Techne Corporation
  • Lonza Group
  • PerkinElmer
  • Cell Biolabs
  • Bio-Rad Laboratories

Q6. Which stem cell assay segment will be the largest in future?

Answer:Lucintel forecasts that viability/cytotoxicity assay will remain the largest segment over the forecast period due to increasing adoption of assays in toxicology and pharmacology application as it helps in determining the number of live and dead cells in a growth medium.

Q7. In stem cell assay market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness the highest growth during the forecast period due to the presence of well-established research infrastructure and increasing government initiatives for stem cell-based research in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1.What are some of the most promising, high-growth opportunities for the stem cell assay market by type (viability or cytotoxicity, isolation and purification, cell identification, proliferation, differentiation, function, apoptosis, and others), cell type (adult, mesenchymal, induced pluripotent, hematopoietic, umbilical cord, neural, human embryonic), product & service (instruments, flow cytometers, microelectrode arrays, cell imaging & analysis systems, automated cell counters, and kits services), application (regenerative medicine & therapy development, orthopedic, musculoskeletal, and spine application, dermatology application, cardiovascular application, CNS application, oncology application, diabetes application, drug discovery & development, and clinical research), end use industry (biopharmaceutical & biotechnology companies and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stem Cell Assay Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Stem Cell Assay Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Stem Cell Assay Market by Assay Type
    • 3.3.1: Viability or Cytotoxicity
    • 3.3.2: Isolation and Purification
    • 3.3.3: Cell Identification
    • 3.3.4: Proliferation
    • 3.3.5: Differentiation
    • 3.3.6: Function
    • 3.3.7: Apoptosis
    • 3.3.8: Others
  • 3.4: Global Stem Cell Assay Market by Cell Type
    • 3.4.1: Adult
    • 3.4.2: Mesenchymal
    • 3.4.3: Induced Pluripotent
    • 3.4.4: Hematopoietic
    • 3.4.5: Umbilical Cord
    • 3.4.6: Neural
    • 3.4.7: Human Embryonic
  • 3.5: Global Stem Cell Assay Market by Product & Service
    • 3.5.1: Instruments
    • 3.5.2: Flow Cytometers
    • 3.5.3: Microelectrode Arrays
    • 3.5.4: Cell Imaging & Analysis Systems
    • 3.5.5: Automated Cell Counters
    • 3.5.6: Kits
    • 3.5.7: Services
  • 3.6: Global Stem Cell Assay Market by Application
    • 3.6.1: Regenerative Medicine & Therapy Development
    • 3.6.2: Orthopedic, Musculoskeletal, and Spine Application
    • 3.6.3: Dermatology Application
    • 3.6.4: Cardiovascular Application
    • 3.6.5: CNS Application
    • 3.6.6: Oncology Application
    • 3.6.7: Diabetes Application
    • 3.6.8: Drug Discovery & Development
  • 3.7: Global Stem Cell Assay Market by End Use Industry
    • 3.7.1: Biopharmaceutical & Biotechnology Companies
    • 3.7.2: Academic & Research Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Stem Cell Assay Market by Region
  • 4.2: North American Stem Cell Assay Market
    • 4.2.1: North American Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.2.2: North American Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.3: European Stem Cell Assay Market
    • 4.3.1: European Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.3.2: European Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.4: APAC Stem Cell Assay Market
    • 4.4.1: APAC Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.4.2: APAC Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes
  • 4.5: ROW Stem Cell Assay Market
    • 4.5.1: ROW Stem Cell Assay Market by Assay Type: Viability/Cytotoxicity, Isolation and Purification, Cell Identification, Proliferation, Differentiation, Function, Apoptosis, and Others
    • 4.5.2: ROW Stem Cell Assay Market by End Use Industry: Biopharmaceutical & Biotechnology Companies and Academic & Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Stem Cell Assay Market by Assay Type
    • 6.1.2: Growth Opportunities for the Global Stem Cell Assay Market by Cell Type
    • 6.1.3: Growth Opportunities for the Global Stem Cell Assay Market by Product & Service
    • 6.1.4: Growth Opportunities for the Global Stem Cell Assay Market by Application
    • 6.1.5: Growth Opportunities for the Global Stem Cell Assay Market by End Use Industry
    • 6.1.6: Growth Opportunities for the Global Stem Cell Assay Market by Region
  • 6.2: Emerging Trends in the Global Stem Cell Assay Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Stem Cell Assay Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stem Cell Assay Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Merck KGaA
  • 7.3: Danaher
  • 7.4: Becton, Dickinson and Company
  • 7.5: Agilent Technologies
  • 7.6: Bio-Techne Corporation
  • 7.7: Lonza Group
  • 7.8: PerkinElmer
  • 7.9: Cell Biolabs
  • 7.10: Bio-Rad Laboratories